Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,646 | 129 | 95.3% |
| Education | $180.55 | 6 | 4.7% |
| Unspecified | $0 | 2 | 0.0% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,301 | 47 | $0 (2024) |
| Janssen Biotech, Inc. | $324.41 | 13 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $232.24 | 10 | $0 (2024) |
| Celgene Corporation | $190.41 | 9 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $172.44 | 8 | $0 (2024) |
| PFIZER INC. | $167.58 | 3 | $0 (2023) |
| Covidien LP | $146.24 | 1 | $0 (2019) |
| CONMED Corporation | $142.06 | 1 | $0 (2019) |
| Synergy Pharmaceuticals Inc | $140.87 | 2 | $0 (2018) |
| GENZYME CORPORATION | $131.73 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,214 | 59 | ABBVIE INC. ($210.74) |
| 2023 | $804.02 | 36 | AbbVie Inc. ($133.58) |
| 2022 | $230.07 | 12 | ABBVIE INC. ($80.58) |
| 2021 | $29.55 | 1 | Celgene Corporation ($29.55) |
| 2020 | $32.74 | 2 | AbbVie Inc. ($18.33) |
| 2019 | $1,027 | 17 | AbbVie, Inc. ($520.38) |
| 2018 | $489.44 | 10 | AbbVie, Inc. ($337.69) |
All Payment Transactions
137 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $13.88 | General |
| Category: Immunology | ||||||
| 12/12/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $21.22 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $23.41 | General |
| Category: Gastroenterology | ||||||
| 12/11/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $4.45 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/10/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $31.62 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/20/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $28.06 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 10/16/2024 | Braintree Laboratories, Inc. | SUTAB (Drug), SUFLAVE | Food and Beverage | In-kind items and services | $13.48 | General |
| Category: GI COLON PREP | ||||||
| 10/15/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $19.53 | General |
| Category: Neuroscience | ||||||
| 10/15/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $2.52 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/09/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $21.69 | General |
| Category: Immunology | ||||||
| 10/07/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $21.88 | General |
| Category: LIVER DISEASE | ||||||
| 09/30/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.85 | General |
| Category: Immunology | ||||||
| 09/19/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $21.03 | General |
| Category: Neuroscience | ||||||
| 09/17/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $20.23 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/12/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $24.75 | General |
| Category: IMMUNOLOGY | ||||||
| 09/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.22 | General |
| Category: Gastroenterology | ||||||
| 09/03/2024 | Celltrion USA Inc. | ZYMFENTRA (Biological) | Education | In-kind items and services | $20.14 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/27/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $28.25 | General |
| Category: IMMUNOLOGY | ||||||
| 08/22/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.33 | General |
| Category: Immunology | ||||||
| 08/12/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $22.77 | General |
| Category: IMMUNOLOGY | ||||||
| 08/07/2024 | Celltrion USA Inc. | ZYMFENTRA (Biological) | Education | In-kind items and services | $19.60 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/06/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $21.78 | General |
| Category: Immunology | ||||||
| 07/16/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $21.37 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 06/26/2024 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $29.30 | General |
| 06/25/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $11.41 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 335 | 374 | $238,688 | $42,693 |
| 2022 | 10 | 359 | 395 | $234,804 | $44,755 |
| 2021 | 13 | 410 | 465 | $272,229 | $55,843 |
| 2020 | 7 | 127 | 139 | $72,295 | $15,072 |
All Medicare Procedures & Services
43 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 47 | 47 | $68,089 | $10,076 | 14.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 63 | 74 | $18,722 | $7,407 | 39.6% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 52 | 57 | $46,712 | $5,309 | 11.4% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 32 | 32 | $37,664 | $2,871 | 7.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 22 | 24 | $7,392 | $2,614 | 35.4% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 14 | 14 | $14,553 | $2,599 | 17.9% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 14 | 14 | $14,553 | $2,508 | 17.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 13 | 25 | $5,363 | $2,489 | 46.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 15 | 15 | $5,198 | $1,987 | 38.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 24 | 27 | $5,049 | $1,822 | 36.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 15 | 21 | $3,234 | $1,258 | 38.9% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 13 | 13 | $9,438 | $1,092 | 11.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 11 | 11 | $2,723 | $660.54 | 24.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 92 | 112 | $27,892 | $10,709 | 38.4% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 43 | 43 | $61,899 | $8,643 | 14.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 40 | 40 | $13,797 | $5,402 | 39.2% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 52 | 56 | $44,626 | $4,856 | 10.9% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 29 | 30 | $9,156 | $3,281 | 35.8% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 30 | 30 | $34,882 | $2,871 | 8.2% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 14 | 15 | $15,309 | $2,697 | 17.6% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 18 | 27 | $5,616 | $2,322 | 41.3% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 14 | 15 | $15,215 | $2,009 | 13.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 27 | 27 | $6,413 | $1,966 | 30.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 75 | 98 | $19,600 | $10,241 | 52.3% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 42 | 42 | $55,314 | $8,992 | 16.3% |
About Michelle Tong
Michelle Tong is a Gastroenterology healthcare provider based in Torrington, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/24/2014. The National Provider Identifier (NPI) number assigned to this provider is 1659798023.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Michelle Tong has received a total of $3,826 in payments from pharmaceutical and medical device companies, with $1,214 received in 2024. These payments were reported across 137 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($3,646).
As a Medicare-enrolled provider, Tong has provided services to 1,231 Medicare beneficiaries, totaling 1,373 services with total Medicare billing of $158,364. Data is available for 4 years (2020–2023), covering 43 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location Torrington, CT
- Active Since 03/24/2014
- Last Updated 02/13/2021
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1659798023
Products in Payments
- Mavyret (Drug) $429.18
- Humira (Biological) $406.77
- STELARA (Biological) $395.72
- RINVOQ (Biological) $263.16
- ENTYVIO (Biological) $209.64
- ZEPOSIA (Drug) $190.41
- XIFAXAN (Drug) $172.44
- CONMED BILIARY (Device) $142.06
- Trulance (Drug) $140.87
- INFLECTRA (Biological) $127.69
- DUPIXENT (Biological) $124.59
- CREON (Drug) $98.60
- OMVOH (Drug) $93.70
- VOQUEZNA (Drug) $93.68
- Epclusa (Drug) $73.47
- ZENPEP (Drug) $67.87
- VOWST (Biological) $66.86
- ZYMFENTRA (Biological) $62.10
- SKYRIZI (Biological) $48.85
- TREMFYA (Drug) $46.03
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Torrington
Dr. Michael Disiena, M.d, M.D
Gastroenterology — Payments: $32,630
Joseph Scirica, Md, MD
Gastroenterology — Payments: $4,616
William Coll, Md, MD
Gastroenterology — Payments: $3,893
Robert Lindenberg, Md, MD
Gastroenterology — Payments: $2,960
Mrs. Angela Murno, Aprn Bc, APRN BC
Gastroenterology — Payments: $2,623
Leslie Goldman, Md, MD
Gastroenterology — Payments: $2,015